Qualitative Study for Finasteride Detection in the Prostate Delivered by Reversible Inhibition of Sperm Under Guidance – Prostate Hair (RISUG-PH) Vas Injectable Implant
April 2025
in “
Journal of Reproductive Healthcare and Medicine
”
Studysummary This study confirmed that an injectable implant known as RISUG-PH™, when administered via the vas deferens, successfully delivers the drug Finasteride to the prostate in male rats for up to 28 days, suggesting a potential localized alternative to oral delivery methods.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on patentimages.storage.googleapis.com →